Fig. 3: Validation of the TIR signature for survival prediction in an independent cohort. | Communications Biology

Fig. 3: Validation of the TIR signature for survival prediction in an independent cohort.

From: A four-gene signature predicts survival and anti-CTLA4 immunotherapeutic responses based on immune classification of melanoma

Fig. 3

a Kaplan–Meier curves of the survival rate of patients in the GSE65904 cohort with high TIR risk scores and those with low TIR risk scores. Statistical significance was determined by the log-rank test. b All patients in the GSE65904 cohort were ranked from the lowest to the highest TIR risk score. c The overall survival time and survival status of individual patients in the GSE65904 cohort. The black dotted line represents the median TIR risk score that divides patients into low-risk and high-risk groups. d Heatmap of SEL1L3, HAPLN3, BST2, and IFITM1 expression levels. Rows represent genes and columns represent patients in the GSE65904 cohort.

Back to article page